Find a Tender
complete
#h6vhtk-06a761
Published 8 Sept 2026, 17:22 BST
Official UK Procurement Procedure
Smallpox Vaccine (Imvanex)
NHS & Healthcare
goods
Above threshold
Direct award
Vaccines
UK
Published value
£1
Submission deadline
Open opportunity
Lots published
1
Contract duration
3 yrs
Electronic Sourcing Gateway:
Published portal
What is being bought & procurement scope
Procurement Scope & Specification
Executive Summary: Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency: "Smallpox Vaccine (Imvanex)". Published status: complete. Published value: £1. 1 published lot. Submission deadline not published. See the official notice for participation instructions.
Official Requirement Description:
The supply of Smallpox Vaccine (Imvanex)
Lots and requirements (1)
Procurement Structure
- Lot 1 · #1Individual lot title not publishedcompletePublished valueNot publishedThe source published no individual title or description for this lot.Contract period:12 Oct 2026 — 11 Oct 2029 (3 yrs)Eligibility:Not published
Qualification snapshot & criteria
Go / No-Go Decision Box
Evaluation weighting
Award criteria weighting not published in structured data — consult the tender pack documents.
Incumbent & Market Position
Top Retained Vendor (Authority Spend)ASTRAZENECA UK LIMITEDHolds 97.7% of historical attributable spend
High ConcentrationEntry requirements & qualification
Turnover Benchmark
Insurance Commitments (No Upfront Purchase Needed)
Accreditations & Security Vetting
Contract Duration & Term OptionsExpected duration: 3 yrs
Published track record for Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency. These figures describe a rolling 24-month window, not a forecast of bids or a measure of buyer bias.
Avg price drop
Not availableEarly / insufficient sample
Competition Density
1Bids / Report (median)
Supplier Concentration
Published spend
£230,803,079Historical spend
Typical award value
£12,000Robust (n=53)
Awarded spend by half-year
2024-H2
2025-H1
2025-H2
2026-H1
2026-H2
Methodology & coverage notes (70 active published awards)
Coverage: 70 active published awards; 37 bid reports (which may be per lot); 53 valued awards. Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Published-to-award variance compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Every figure carries an evidence level: Robust (5+ observations), Moderate (3–4), Indicative (1–2). Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Historical Awarded Suppliers in this Category (CPV 33):
Supplier Name | Historic Awards | Attributable Value | Avg. Price Discount |
|---|---|---|---|
| ASTRAZENECA UK LIMITED | 1 win | £225,408,000 | No published budget |
| Associates of Cape Cod International Inc. | 1 win | £2,900,000 | No published budget |
| Takara Bio Europe SAS | 1 win | £612,360 | No published budget |
| IDEXX LABORATORIES LIMITED | 1 win | £350,000 | No published budget |
| Bruker Spatial Biology, Inc. | 2 wins | £222,372 | No published budget |
Sector Market Benchmark & Opportunity Radar
CPV 33 · UK Sector Analysis
Observed CPV-sector evidence
Prepared 8 Sept 2026, 19:06 BST
Observed CPV-sector evidence where it exists, with clearly labelled UK all-sector context for sparse fields; this is market context, not a bid forecast.
Median Winning Discount
0.41%
Typical Bids Received
2reported bids
Decision Velocity
~66 days
Notice Stability
2 updates
Historical Incumbency: PFIZER LIMITED has won 7 previous contracts with this contracting authority in this sector.
Procurement history indicates repeat engagement with this buyer in this sector. All public competitions remain open to qualifying tenderers under UK procurement regulations.
Top Contenders in this Sector (CPV 33)
Supplier | Awards won | Total awarded value | Avg. winning discount |
|---|---|---|---|
GILEAD SCIENCES LTDCRN: PPDW-8775-RCQV | 43 contracts | £8,430,726,286 | At ceiling / not disclosed |
| 8 contracts | £3,688,690,460 | At ceiling / not disclosed | |
| 1 contract | £3,240,000,000 | At ceiling / not disclosed | |
Merck Sharpe & Dohme (UK) LimitedCRN: 233687 | 41 contracts | £2,400,000,005 | At ceiling / not disclosed |
Bio Products Laboratory LtdCRN: 07343036 | 22 contracts | £1,604,223,396 | At ceiling / not disclosed |
| 2 contracts | £1,540,500,000 | At ceiling / not disclosed | |
ABBVIE LTDCRN: PHRQ-1133-WGCH | 62 contracts | £1,211,373,117 | At ceiling / not disclosed |
| 2 contracts | £1,000,000,000 | At ceiling / not disclosed | |
Fortem Solutions LimitedCRN: 04638969 | 6 contracts | £700,000,000 | At ceiling / not disclosed |
| 8 contracts | £602,156,209 | At ceiling / not disclosed |
Comparable Published Opportunities & Re-tender Precedents
Historic records ranked from matching published evidence. They serve as research precedents for contract scoping, specifications, and previous awardees.
Published procedure | Published value | Matching evidence |
|---|---|---|
Countermeasures and Preparedness ProductsSecretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · 31 Jul 2026, 12:05 BST | £1 | same CPV family same authority same region similar value band |
The supply of Pralidoxime Chloride 2026Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · 14 Aug 2026, 14:58 BST | £1 | same CPV family same authority same region similar value band |
The supply of Doxycycline 10 pack 2027Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · 21 Aug 2026, 16:02 BST | £1 | same CPV family same authority same region similar value band |
UKHSA Diagnostics & Research Open FrameworkSecretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · 4 Sept 2026, 10:44 BST | £6,250,000,000 | same CPV family same authority same region |
Provision of immunisations which protect against, diphtheria, tetanus, pertussis, polio, Haemophilus influenzae type b (Hib) and hepatitis B programmes (2028).Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · 4 Aug 2026, 16:00 BST | Value not published | same CPV family same authority same region |
Method: tender-intelligence-v1. Empirical OCDS facts and cross-sector percentiles; missing fields remain unrecorded.
Procedure terms & legal framework
| Procedure method | Direct award | Legal basis | UKPGA · 2023/54 Procurement Act 2023 | Procurement category | goods |
|---|---|---|---|---|---|
| Notice status | complete | Procurement threshold | Above threshold (FTS publication) | Regulatory regime | Standard commercial regime |
| Commercial structure | Stand-alone contract (No framework) | Competition type | Competitive procedure | GPA WTO covered | Unspecified in notice |
| Recurring procurement | No (One-off requirement) | First published | 8 Sept 2026, 17:22 BST | Last source update | 8 Sept 2026, 17:22 BST |
| Estimated future notice | 27 Jul 2026, 23:59 BST | Classification (CPV) | Vaccines | ||
| Delivery area | UK | ||||
| Official Registry OCID | ocds-h6vhtk-06a761 | ||||
Timeline
- Pipeline notice
28 May 2026, 11:44 BST - Procedure published
8 Sept 2026, 17:22 BST - engagement
11 Jun 2026, 23:59 BST · scheduledSuppliers are invited to submit responses including the following: Product Information: - Product name and description - Available dose/pack sizes and formats Pricing Information: - Unit pricing - Volume-based pricing and price breaks - Any minimum order quantities Lead Times and Supply: - Standard lead times - Availability and production capacity Regulatory / Licensing: - Licensing status Storage and Handling: - Storage conditions (e.g. temperature requirements) - Shelf life If your organisation is interested in this requirement, please provide the above information to [email protected] by COP 11th June 2026. - Award pending
8 Sept 2026, 00:00 BST · £1 - Standstill period concludes
18 Sept 2026, 23:59 BST (PCR 2015 10-day moratorium)
Commercial outcome and contract awards
Awards (1) Bavarian Nordic A/S £1 · 8 Sept 2026, 00:00 BST · pending · lots 1 Standstill concludes: 18 Sept 2026, 23:59 BST(PCR 2015 10-day moratorium before contract signing) |
Contracts (0)No contract published |
Bid statisticsNo aggregate bid statistics published |
Notice history
From official release and amendment events
- Official notice release published
8 Sept 2026, 17:22 BST - tender value changed
8 Sept 2026, 17:18 BST - Status changed to complete
8 Sept 2026, 17:18 BST - Official notice release published
8 Sept 2026, 17:18 BST - procurement method changed
8 Sept 2026, 17:18 BST - Official notice release published
28 May 2026, 11:44 BST
Buyer and organisations in this procedure
1 participating organisation
Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency
Contracting authority
NHS & Healthcare
Award and contract changes
Official Documents & Specifications (4)
Official links; attachments are not copied
- 8 Sept 2026, 17:22 BST
- 8 Sept 2026, 17:18 BST
- 28 May 2026, 11:44 BST
Procedure justification & pre-market engagement
Official Statement
| Procedure rationale (direct award / limited competition) | Section 41 Single Supplier for third-generation smallpox vaccine |
|---|